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Key Clinical Message
We report the first case of wound infection caused by Trueperella bernardiae
after laparoscopic surgery. The patient was treated with oral amoxicillin/clavu-
lanate which was continued for 1 week after discharge with a successful clinical
response. There are few cases described but none related to wound infection
after laparoscopic surgery.
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Introduction
Trueperella bernardiae is a nonspore-forming, nonmotile,
facultative anaerobic, gram-positive coccobacilli; it is cata-
lase and oxidase negative and has variable hemolytic
activity. Colonies are circular, smooth, and slightly convex
with a glassy appearance and diameters range from 0.2 to
0.5 mm [1].
This bacterium was first described as a likely opportunis-
tic pathogen based on its morphological, biochemical, and
chemical properties as part of Coryneform Group 2 [2].
This group was characterized using biochemical and
chemotactic methods (16S rRNA sequence analysis) from
bacteria isolated from blood samples and human
abscesses and the name Actinomyces bernardiae sp. nov.
was proposed [3]. It was classified as part of the genus
Arcanobacterium [1] and was later reclassified as part of
the genus Trueperella [4].
There are some documented cases of infection caused by
Trueperella bernardiae. These bacteria usually come from
the skin as it can be part of the regular skin flora [5].
Trueperella bernardiae was previously identified from
blood culture, abscesses, and eye infections [3]. There are
case reports of severe urinary tract infections complicated
by septicemia [6], septic arthritis [7], coinfection with
Staphylococcus aureus from chronic osteitis [8], prosthetic
joint infection [9], necrotizing fasciitis [10], bacteremia
secondary to soft tissue infection [11], bacteremia due to
chronic ulcers of the lower limbs [5], diabetic foot infec-
tion, and sepsis [12].
As far as we know, this report describes the first case of
wound infection caused by Trueperella bernardiae after
laparoscopic cholecystectomy.
Case Report
In December 2014, a 24 year-old woman was admitted to
the Emergency Unit of the Hospital of Corac~ao in S~ao
Paulo, Brazil, with fever, pain, and purulent periumbilical
secretion 7 days after a laparoscopic cholecystectomy
intervention in Belem, Para, located in the northern
region of Brazil. The patient has no immunologic
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impairment. She underwent cholecystectomy because she
was found to have biliar stones and previous biliar colic.
Medical examination revealed painful cellulitis with
purulent drainage in the periumbilical region. Laboratory
data included a blood leukocyte count of 15,610/mm3,
neutrophil count of 11,551/mm3, platelet count of
489,000/mm3, C-reactive protein level of 90 mg/L and
ESR of 42 mm. Computerized tomography showed a
4 9 3.5 9 2.5 cm infraumbilical collection with local
subcutaneous fat densification and also ultrasonography
(Figs. 1 and 2). Both anaerobic and aerobic blood cul-
tures were negative. The Gram stain of the umbilical
purulent secretion showed a moderate number of leuko-
cytes and gram-positive short bacilli suggesting coryne-
form bacteria. The initial direct aerobic culture assembled
in Sheep Blood Agar (SBA), Chocolate Agar (CA), and
MacConkey Agar (MCA) plates was negative after 48 h,
but after 4 days of incubation in enrichment broth (thio-
glycolate with resazurin), the culture was positive and
subcultured in SBA, CA, and MCA plates when we iso-
lated in SBA and CA, a facultative anaerobic beta-hemoly-
tic gram-positive bacilli that was not initially identified by
Vitek 2 (bioMerieux Marcy l’etoile, France).
Trueperella bernardiae was identified by Vitek MS
(bioMerieux) mass spectrometry (matrix-assisted laser
desorption/ionization time-of-flight [MALDI-TOF]). A
disk diffusion (DD) in Mueller Hinton Blood Agar test
showed resistance to erythromycin and clindamycin (zone
diameter inhibition = 6 mm) and susceptibility to levo-
floxacin and linezolid using the CLSI DD criteria for Sta-
phylococcus spp., and susceptibility to vancomycin using
criteria for Enterococcus spp.. These results may be con-
troversial, since there are no DD breakpoints for Actino-
myces or coryneform bacteria given by CLSI or EUCAST
[13–15]. The minimal inhibitory concentration (MIC) for
penicillin, as determined by Etest (bioMerieux), was
0.064 lg/mL, which was considered susceptible. Because
there is no specific MIC breakpoint for benzylpenicillin
described by Clinical and Laboratory Standard Institute
(CLSI), we used EUCAST breakpoints for gram-positive
anaerobes including Actinomyces spp, with reference values
of ≤0.25 lg/mL for considering penicillin susceptibility
[15].
A combination of 4.5 g of piperacillin/tazobactam and
1 g of vancomycin was given intravenously every 8 h
until the microbiological results were available. After
6 days of hospitalization, laboratory parameters
improved, showing a leukocyte count of 9580/mm3. Also,
the skin lesion showed improvement. Based on these
results, the treatment was changed to oral amoxicillin/
clavulanate which was continued for 1 week after
discharge with a successful clinical response. We sought
to change amoxicillin/clavulanate for a penicillin but the
assistant physician insisted on utilizing a b-lactamic/
b-lactamase inhibitor.
Discussion
The virulence of Trueperella bernardiae is unclear, and its
occurrence is rare. This pathogen is usually susceptible to
several antibiotics, but differences in its microbiological
profile have been described.
As far as we know, this is the first report of Trueperella
bernardiae causing a wound infection after laparoscopic
cholecystectomy. In this report, Trueperella bernardiae
was resistant to clindamycin and erythromycin. This
result differs from the findings of other studies, in which
all samples from Canada, USA, and Switzerland were sus-
ceptible to all antimicrobial drugs except ciprofloxacin
Figure 1. Computerized tomography showing infraumbilical
collection with local subcutaneous fat densification.
Figure 2. Ultrasonography showing infraumbilical collection with
local subcutaneous fat densification.
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[3]. The bacterium was susceptible to erythromycin,
piperacillin/tazobactam, linezolid, moxifloxacin, and
rifampicin and resistant to norfloxacin and fosfomycin in
previous studies [5, 12]. There are also reports of differ-
ent MIC values for penicillin in previous studies (e.g.,
≤0.03 lg/mL [3], 0.016 lg/mL [5], 0.25 lg/mL [12], and
0.064 lg/mL in our study).
In this case report, piperacillin/tazobactam and van-
comycin were used as empirical therapy. After laboratory
confirmation of the presence of Trueperella bernardiae, we
suggested narrowing the antibiotic spectrum to penicillin
or amoxicillin but the suggestion was refused and the
treatment was de-escalated to oral amoxicillin/clavulanate,
which resulted in a favorable clinical outcome. Otto et al.
[5] also successfully used amoxicillin/clavulanate as a
directed therapy, while Schneider et al. [12] used amoxi-
cillin isolatedly.
The identification of Trueperella bernardiae is difficult
because it can sometimes be confused with streptococci
and other coryneform or non-diphtheroid gram-positive
bacilli [5, 16]. These microorganisms are frequently not
accurately identified by the Vitek 2 or API systems
(bioMerieux) and reliable identification often requires
confirmation by molecular methods, including PCR and
DNA sequencing. The use of MALDI-TOF mass spec-
trometry might represent an alternative to 16S rRNA gene
sequencing and might replace these time-consuming and
expensive techniques for the majority of difficult-to-iden-
tify isolates in the clinical microbiology laboratory
[17–19]. This new technology is an important resource
for the rapid identification of less frequent microorgan-
isms bringing more elucidative aspects of certain kind of
infections and helping to choose the more suitable
antimicrobial therapy.
This case illustrates the first occurrence of Trueperella
bernardiae in Brazil. Our study reinforces the need to
identify aerobic, nonspore-forming, gram-positive bacilli
obtained in pure cultures even from nonsterile sources. A
complete understanding of the role of this microorganism
as a causative pathogen of infection is needed.
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